Emergent BioSolutions Statistics
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.05-0.10 (-1.94%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Emergent BioSolutions by the numbers
Emergent BioSolutions has a market capitalization of $259.6 million based on 51.42M shares outstanding. With trailing EPS of $-5.00, Emergent BioSolutions is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.7% below its 50-day average and 33.4% below its 200-day average.
Average daily trading volume is 1.11M shares, or about $5.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EBS valuation vs. peer median
| Metric | EBS | Peer median | Difference |
|---|---|---|---|
| Market cap | $259.65M | $258.72M | +0% |
| Avg. volume | 1.11M | 423.72K | +162% |
Peer median across 8 companies: ALT, PRLD, VCRE, QTTB, GALT, TTRX, LFCR, RLMD.
Valuation
- Market cap
- $259.65M
- Forward P/E
- 4.83
- Price / sales (latest FY)
- 0.35
- EPS (TTM)
- $-5.00
- Shares outstanding
- 51.42M
Price and trading
- Previous close
- 5.15
- Open
- 5.08
- Day range
- 4.98 – 5.24
- 52-week range
- 4.36 – 14.06
- 52-week change
- -49.70%
- Beta
- —
- Volume
- 1.39M
- Average volume
- 1.11M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 259.65M
- Forward Pe
- 4.83
- Eps
- -5.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.06
- Week52 Low
- 4.36
- Avg Volume
- 1.11M
- Shares Outstanding
- 51.42M
- Ma50
- 6.45
- Ma200
- 7.59
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -64.08%
- Pct From52w Low
- 15.83%